Joslin Leadership

Critical to the success of a world-class institution like Joslin is solid leadership. To maintain the Center's level of excellence in diabetes research, care and education; Joslin's Boards of Trustees and Overseers work in tandem with the executive team.

Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge – a hallmark of this one-of-a-kind Center.

Publicly representing the institution, Joslin's Board of Trustees comprises local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of a future without diabetes.

Board of Trustees

Peter S. Amenta, M.D., Ph.D. - University of Medicine and Dentistry of NJ, Robert Wood Johnson Medical School, New Brunswick, NJ

John J. Cook, Jr. - Managing Director, Seaward Management Corp., Boston, MA

Nathaniel S. Gardiner - Edwards Wildman Palmer LLP, Boston, MA

Morella M. Grossmann - Caracas, Venezuela

Ralph M. James, Chairperson of the Board - Executive Director, External Relations, Harvard Business School, Boston, MA

Ann M. Lagasse - Newburyport, MA

James L. Peterson - Corseaux, Switzerland

Geoffrey S. Rehnert - Founder and Co-CEO, Audax Group, Boston, MA

Mark E. Russell - Vice President, Raytheon Company, Waltham, MA

Richard A. Smith - Chestnut Hill, MA

Ex Officio

John L. Brooks III - President and CEO, Joslin Diabetes Center, Boston, MA

Martin J. Abrahamson, M.D. - Senior Vice President and Chief Medical Officer, Joslin Diabetes Center, Boston, MA

George L. King, M.D. - Senior Vice President and Chief Scientific Officer, Joslin Diabetes Center, Boston, MA

Honorary Trustees

W. Ray Allen - Coral Gables, FL

Charles H. Hood - Brookline, MA

Patrick H. O’Neill - New Canaan, CT

Kenneth E. Quickel, M.D. - Oak Park Heights, MN